Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 14, Issue 3, 2005, Pages 115-119

  Angelova Fischer, Irena ^a   Tsankov, N ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Atopic dermatitis; Cysteinyl leukotriene receptor antagonists; Montelukast; Steroid sparing treatment

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PETROLATUM;

ADULT; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; CLINICAL FEATURE; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MEDICAL EXAMINATION; REMISSION; SCORING SYSTEM; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT OUTCOME;

ACETATES; ADULT; DERMATITIS, ATOPIC; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; QUINOLINES;

EID: 24744470041     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Severity scoring of atopic dermatitis: the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
2. Kägi M. Leukotriene receptor antagonists-a novel therapeutic approach in atopic dermatitis? Dermatology 2001; 203: 280-3.
3. Zhang J, Chervinsky P, Edwards T, et al. Montelukast, a CysLT1 receptor antagonist, decreases peripheral blood eosinophils and improves signs and symptoms of asthma over a 3-month period. J Allergy Clin Immunol 1997; 99: 268.
4. Ellis MH. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 1998; 102: 876-7.
5. Nettis E, Dambra P, D'Oronozio L, et al. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol 2001; 137: 99-100.
6. Carucci J, Washenik K, Weinstein A, et al. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 1998; 134: 785-86.
7. Galindo G, Zuniga L, Gonzales-Dias S. Use of montelukast in the treatment of atopic dermatitis: a case report. Ann Allergy Asthma Immunol 2000; 84: 154.
8. Drazen J, Israel E, O'Byrne P. Treatment of asthma with drugs modifying the leukotriene pathway. N Eng J Med 2000; 340: 197-206.
9. Byrne P. Leukotrienes in the pathogenesis of asthma. Chest 1997; 111: 27-34.
10. Lewis R, Austen K, Soberman R. Leukotriene and other products of the 5-lypoxygenase pathway: biochemistry and pathobiology in human diseases. N Eng J Med 1990; 323: 645-55.
11. Busse W. Leukotrienes and inflammation. Am J Respir Crit Care Med 1998; 157: 210-13.
12. Penrose J, Spector J, Baldasaro M, et al. Molecular cloning of the gene for human leukotriene C4 synthase. Organization, nucleotide sequence and chromosomal location to 5q35. J Biol Chem 1996; 271: 11356-61.
13. Coleman R et al. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on the classification and nomenclature. In Samuelson B, et al, editors. Advances in prostaglandin, leukotriene and thromboxan research, vol.23. New York, Raven Press; 1994, 283-5.
14. Metters K. Leucotriene receptors. J Lipid Mediat Cell Signal 1995; 12: 413-27.
15. Lynch K, O'Neill G, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999; 399: 789-93.
16. Figueroa D, Breyer R, Defoe S, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med 2001; 163: 226-33.
17. Donnelly A, Glass M, Minkwitz M, Casale T. The leukotriene D4-receptor antagonist, ICI 204, 219 relieves the symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995; 151: 1734-9.
18. Capella G, Frigerio E, Altomare G. A randomized trial of leukotriene receptor antagonist montelukast in moderate-to-severe atopic dermatitis of adults. Eur J Dermatol 2001; 11: 209-11.
19. Yanase D, David-Bajar K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol 2001; 44: 89-93.
20. Pei A, Chan H, Leung T. Montelukast in the treatment of children with moderate-to-severe atopic dermatitis: a pilot study. Pediatr Allergy Immunol 2001; 12: 154-8.
21. Broshtilova V, Antonov D, Bardarov E, Tsankov N. Severe erythrodermic atopic dermatitis treated with montelukast. Skinmed 2003; 2: 134-6.